Sökning: WFRF:(Rentoft Matilda) > (2020-2022) > Pan-cancer analysis...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08921naa a2201153 4500 | |
001 | oai:DiVA.org:umu-200663 | |
003 | SwePub | |
008 | 221107s2022 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:821f045b-0aa5-4df0-91e3-54c8563b2479 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2006632 URI |
024 | 7 | a https://doi.org/10.1186/s12916-022-02553-42 DOI |
024 | 7 | a https://lup.lub.lu.se/record/821f045b-0aa5-4df0-91e3-54c8563b24792 URI |
040 | a (SwePub)umud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Breeur, Marieu International Agency for Research on Cancer, World Health Organization4 aut |
245 | 1 0 | a Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition |
264 | c 2022-10-19 | |
264 | 1 | b BioMed Central (BMC),c 2022 |
338 | a electronic2 rdacarrier | |
520 | a Background: Epidemiological studies of associations between metabolites and cancer risk have typically focused on specific cancer types separately. Here, we designed a multivariate pan-cancer analysis to identify metabolites potentially associated with multiple cancer types, while also allowing the investigation of cancer type-specific associations.Methods: We analysed targeted metabolomics data available for 5828 matched case-control pairs from cancer-specific case-control studies on breast, colorectal, endometrial, gallbladder, kidney, localized and advanced prostate cancer, and hepatocellular carcinoma nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. From pre-diagnostic blood levels of an initial set of 117 metabolites, 33 cluster representatives of strongly correlated metabolites and 17 single metabolites were derived by hierarchical clustering. The mutually adjusted associations of the resulting 50 metabolites with cancer risk were examined in penalized conditional logistic regression models adjusted for body mass index, using the data-shared lasso penalty.Results: Out of the 50 studied metabolites, (i) six were inversely associated with the risk of most cancer types: glutamine, butyrylcarnitine, lysophosphatidylcholine a C18:2, and three clusters of phosphatidylcholines (PCs); (ii) three were positively associated with most cancer types: proline, decanoylcarnitine, and one cluster of PCs; and (iii) 10 were specifically associated with particular cancer types, including histidine that was inversely associated with colorectal cancer risk and one cluster of sphingomyelins that was inversely associated with risk of hepatocellular carcinoma and positively with endometrial cancer risk.Conclusions: These results could provide novel insights for the identification of pathways for cancer development, in particular those shared across different cancer types. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Breast | |
653 | a Cancer | |
653 | a Colorectal | |
653 | a Endometrial | |
653 | a EPIC | |
653 | a Kidney | |
653 | a Lasso | |
653 | a Liver | |
653 | a Metabolomics | |
653 | a Prostate | |
653 | a Breast | |
653 | a Cancer | |
653 | a Colorectal | |
653 | a Endometrial | |
653 | a EPIC | |
653 | a Kidney | |
653 | a Lasso | |
653 | a Liver | |
653 | a Metabolomics | |
653 | a Prostate | |
700 | 1 | a Ferrari, Pietrou International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Dossus, Laureu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Jenab, Mazdau International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Johansson, Mattiasu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Rinaldi, Sabinau International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Travis, Ruth C.u University of Oxford4 aut |
700 | 1 | a His, Mathildeu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Key, Tim J.u University of Oxford4 aut |
700 | 1 | a Schmidt, Julie A.u University of Oxford,Aarhus University Hospital4 aut |
700 | 1 | a Overvad, Kimu Aarhus University4 aut |
700 | 1 | a Tjønneland, Anneu Danish Cancer Society4 aut |
700 | 1 | a Kyrø, Cecilieu Danish Cancer Society4 aut |
700 | 1 | a Rothwell, Joseph A.u Versailles Saint-Quentin-en-Yvelines University4 aut |
700 | 1 | a Laouali, Nasseru Versailles Saint-Quentin-en-Yvelines University4 aut |
700 | 1 | a Severi, Gianlucau Versailles Saint-Quentin-en-Yvelines University4 aut |
700 | 1 | a Kaaks, Rudolfu German Cancer Research Centre4 aut |
700 | 1 | a Katzke, Verenau German Cancer Research Centre4 aut |
700 | 1 | a Schulze, Matthias B.u German Institute of Human Nutrition4 aut |
700 | 1 | a Eichelmann, Fabianu German Center for Diabetes Research,German Institute of Human Nutrition4 aut |
700 | 1 | a Palli, Domenicou Institute for Cancer Research, Prevention and Clinical Network (ISPRO)4 aut |
700 | 1 | a Grioni, Sarau Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Panico, Salvatoreu University of Naples Federico II4 aut |
700 | 1 | a Tumino, Rosario4 aut |
700 | 1 | a Sacerdote, Carlottau Citta' della Salute e della Scienza Hospital-University of Turin4 aut |
700 | 1 | a Bueno-de-Mesquita, Basu National Institute for Public Health and the Environment (RIVM)4 aut |
700 | 1 | a Olsen, Karina Standahlu UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Sandanger, Torkjel Manningu UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Nøst, Therese Haugdahlu UiT The Arctic University of Norway, Tromsø4 aut |
700 | 1 | a Quirós, J. Ramónu Public Health Directorate4 aut |
700 | 1 | a Bonet, Catalinau Bellvitge University Hospital-IDIBELL4 aut |
700 | 1 | a Barranco, Miguel Rodríguezu Andalusian School Of Public Health (EASP),CIBER Epidemiology and Public Health (CIBERESP)4 aut |
700 | 1 | a Chirlaque, María-Doloresu University of Murcia,CIBER Epidemiology and Public Health (CIBERESP)4 aut |
700 | 1 | a Ardanaz, Evau CIBER Epidemiology and Public Health (CIBERESP),Health Research Institute of Navarra (IDISNA)4 aut0 (Swepub:lu)extLU-05 |
700 | 1 | a Sandsveden, Malteu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Surgery,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)ma6468sa |
700 | 1 | a Manjer, Jonasu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Surgery,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital4 aut0 (Swepub:lu)smi-jma |
700 | 1 | a Vidman, Lindau Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)livi0018 |
700 | 1 | a Rentoft, Matildau Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)maaret01 |
700 | 1 | a Muller, Davidu Imperial College London4 aut |
700 | 1 | a Tsilidis, Kostasu Imperial College London4 aut |
700 | 1 | a Heath, Alicia K.u Imperial College London4 aut |
700 | 1 | a Keun, Hectoru Imperial College London4 aut |
700 | 1 | a Adamski, Jerzyu University of Ljubljana,Helmholtz Zentrum München,National University of Singapore4 aut |
700 | 1 | a Keski-Rahkonen, Pekkau International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Scalbert, Augustinu International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Gunter, Marc J.u International Agency for Research on Cancer, World Health Organization4 aut |
700 | 1 | a Viallon, Vivianu International Agency for Research on Cancer, World Health Organization4 aut |
710 | 2 | a International Agency for Research on Cancer, World Health Organizationb University of Oxford4 org |
773 | 0 | t BMC Medicined : BioMed Central (BMC)g 20:1q 20:1x 1741-7015 |
856 | 4 | u https://doi.org/10.1186/s12916-022-02553-4y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1709067/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://dx.doi.org/10.1186/s12916-022-02553-4x freey FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-200663 |
856 | 4 8 | u https://doi.org/10.1186/s12916-022-02553-4 |
856 | 4 8 | u https://lup.lub.lu.se/record/821f045b-0aa5-4df0-91e3-54c8563b2479 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy